Free Trial
ETR:SAZ

STADA Arzneimittel Aktiengesellschaft (SAZ) Stock Price, News & Analysis

STADA Arzneimittel Aktiengesellschaft logo
€80.40 0.00 (0.00%)
As of 11/27/2018

About STADA Arzneimittel Aktiengesellschaft Stock (ETR:SAZ)

Key Stats

Today's Range
€79.56
€80.98
50-Day Range
€80.40
€80.40
52-Week Range
€53.41
€80.98
Volume
92,068 shs
Average Volume
51,761 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

STADA Arzneimittel Aktiengesellschaft engages in the development and marketing of pharmaceutical products for the health care and pharmaceutical markets worldwide. It operates through two segments, Generics and Branded Products. The Generics segment provides various generic active ingredients, including Tilidin Naloxone for pain; Atorvastatin for elevated cholesterol levels; Epoetin zeta for anemia; Diclofenac for pain/inflammation; and Pantoprazole for gastric ulcer/reflux. The Branded Products segment offers APO-Go a Parkinson's medicine; Grippostad a cold medicine; Aqualor for rhinitis/sore throat; Snup for rhinitis; and Vitaprost for prostate disease indications. The company is also involved in the wholesale activities in the pharmaceutical market. It serves patients and consumers, doctors, pharmacies and pharmacy chains, hospitals, mail-order companies, buying groups, wholesalers, and other service providers in the health care market, as well as public or private health insurance organizations. The company was founded in 1895 and is headquartered in Bad Vilbel, Germany. STADA Arzneimittel Aktiengesellschaft is a subsidiary of Nidda Healthcare Holding GmbH.

Receive SAZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STADA Arzneimittel Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

SAZ Stock News Headlines

Here’s How to Claim Your Stake in Elon’s Private Company, xAI
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
Arzneihersteller Stada hat Russland-Geschäft abgespalten
PTA-HV: Deutsche Real Estate Aktiengesellschaft: -3-
See More Headlines

SAZ Stock Analysis - Frequently Asked Questions

STADA Arzneimittel Aktiengesellschaft's stock was trading at €80.40 at the start of the year. Since then, SAZ stock has increased by 0.0% and is now trading at €80.40.
View the best growth stocks for 2025 here
.

Based on aggregate information from My MarketBeat watchlists, some other companies that STADA Arzneimittel Aktiengesellschaft investors own include ProSiebenSat.1 Media (PSM), Renault (RNO), Volkswagen Aktiengesellschaft (VLKAY), Volkswagen (VOW3), Andersons (ANDE), Nuwellis (CHFS) and Chemed (CHE).

Industry, Sector and Symbol

Stock Exchange
ETR
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
ETR:SAZ
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (ETR:SAZ) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners